Mr. Speaker, in a few seconds the Leader of the Reform Party will rise to accuse me of investing too much in Montreal on Monday, by helping Bombardier develop a new 70 seat aircraft to take advantage of an increasingly accessible market. We have been helping this company for a very long time. It is now the sixth largest aircraft manufacturer in the world and very soon will rank fourth. The company received $85 million on Monday. We have to choose our priorities, and that is the one we chose.
As for the pharmaceutical industry, the legislation is in effect. There will be a review at some time, as required by law. We will have to see whether the pharmaceutical industry is fulfilling its obligations to engage in research and development and to locate facilities in Canada, and if it is, the legislation will be maintained. The industry has made certain commitments which I hope it has met. When the House of Commons reviews this question, a decision can be made. It is true that in the past three years there has been pressure to amend the legislation, but we have not done so. The leader of the opposition does not seem to be aware of that fact.